<DOC>
	<DOCNO>NCT01744379</DOCNO>
	<brief_summary>This study explore safety , tolerability , serum uric acid lower effect lesinurad healthy Japanese male allow comparison Western population .</brief_summary>
	<brief_title>Single Multiple Dose Study Japanese</brief_title>
	<detailed_description>While extensive clinical experience lesinurad Western population , recognize intrinsic extrinsic factor may impact PK , PD , safety , dose response different ethnic population . The purpose study explore safety , tolerability , pharmacokinetic ( PK ) , pharmacodynamic ( PD ) single multiple dos lesinurad healthy Japanese male , allow comparison parameter Western population .</detailed_description>
	<mesh_term>Lesinurad</mesh_term>
	<criteria>Able understand study procedure , risk involve willing provide write Informed Consent first study related activity . Healthy adult subject bear Japan All laboratory parameter within normal limit consider clinically significant investigator . Screening serum uric acid level &gt; = 4.5 mg/dL . Subjects must free clinically significant disease require physician 's care and/or would interfere study evaluation procedure . Subject clinically relevant abnormality blood pressure , heart rate , body temperature , respiratory rate , per Investigator 's judgment . Positive serology Human Immunodeficiency Virus ( HIV1 HIV2 ) . Positive test active Hepatitis B Hepatitis C infection . History kidney stone . Undergone major surgery within 3 month Day 1 . Subject receive last dose investigational drug ( treatment medical device ) within 30 day 5 halflives ( whichever longer ) investigational drug prior Day 1 currently participate another study investigational drug ( medical device ) . Prior exposure lesinurad ( RDEA594 ) RDEA806 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>